in this heterogeneous series , the malignancy group ( based on pathologic diagnosis ) was the only factor significantly affecting tumor control probability , which at 5 years was 58 % for 12 patients with group i tumors , 32 % for 10 patients with group ii tumors , and 17 % for 50 patients with group iii tumors .
C0006826
malignancy
C0027651
tumors